What hemodynamic profile characterizes heart failure with preserved ejection fraction (HFpEF) and diastolic dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Heart Failure with Preserved Ejection Fraction: Hemodynamic Profile

Heart failure with preserved ejection fraction (HFpEF) and diastolic dysfunction is characterized by normal LV end-diastolic volume, normal end-systolic volume, and elevated end-diastolic pressure (Option A). This is the fundamental hemodynamic signature that distinguishes HFpEF from other forms of heart failure.

Core Hemodynamic Features

The defining hemodynamic profile of HFpEF includes 1:

  • Preserved LVEF ≥45-50% (normal systolic function)
  • Normal or near-normal LV chamber volumes (both end-diastolic and end-systolic)
  • Elevated LV filling pressures (increased end-diastolic pressure)
  • Evidence of diastolic dysfunction on echocardiography

This contrasts sharply with heart failure with reduced ejection fraction (HFrEF), where LV dilation with increased end-diastolic volumes is the hallmark. In HFpEF, the ventricle maintains normal size but becomes stiff and non-compliant, leading to elevated pressures despite normal volumes 2, 1.

Why the Other Options Are Incorrect

Options C and D are wrong because they describe elevated LV end-diastolic volume, which indicates ventricular dilation—the pathophysiology of HFrEF, not HFpEF. When the ventricle dilates, ejection fraction falls because stroke volume cannot keep pace with the enlarged chamber size 1.

Option B is incorrect because it describes normal end-diastolic pressure. The entire clinical syndrome of HFpEF depends on elevated filling pressures causing pulmonary congestion and dyspnea. Normal filling pressures would not produce heart failure symptoms 1.

Diagnostic Confirmation

The diagnosis requires three components 1:

  1. Clinical signs/symptoms of heart failure (dyspnea, fatigue, edema)
  2. Preserved LVEF ≥45-50% on echocardiography
  3. Evidence of diastolic dysfunction, demonstrated by:
    • E/e' ratio ≥13-15 (elevated filling pressures) 2, 3
    • Left atrial enlargement (volume index >34 mL/m²)
    • Elevated natriuretic peptides
    • Restrictive mitral inflow pattern

Key Pathophysiologic Insight

The preserved ejection fraction in HFpEF is somewhat misleading. EF is maintained because both the numerator (stroke volume) and denominator (end-diastolic volume) remain normal or only mildly reduced 1. The problem is not contractility but rather impaired relaxation and increased chamber stiffness, which prevents adequate filling at normal pressures. To achieve adequate filling, pressures must rise—this is what causes symptoms 2.

Common Diagnostic Pitfall

Do not confuse preserved EF with normal cardiac function. Many clinicians mistakenly assume that normal EF means the heart is working well. In HFpEF, the heart has significant functional impairment despite normal EF. The elevated filling pressures cause backward transmission to the pulmonary circulation, resulting in dyspnea and exercise intolerance 4, 5. The E/e' ratio is the most validated single parameter for estimating these elevated pressures non-invasively, though it has only modest correlation (r=0.56) with invasive measurements 3.

Related Questions

Can residual edema from recent fluid retention in a newly diagnosed heart failure with preserved ejection fraction (HFpEF) cause soft, palpable lumps on the arms, legs, knees, and elbows?
In a 62‑year‑old woman with newly diagnosed heart failure with preserved ejection fraction, lumbar spinal stenosis, cervical spinal stenosis, and right lateral thigh neuropathy, what management steps would a cardiologist take after a technetium‑99m pyrophosphate (PYP) scan showing grade 1 uptake (H/CL ratio 0.84)?
In an 81-year-old male with heart failure with preserved ejection fraction (HFpEF), a pacemaker, prior coronary artery bypass graft (CABG), diabetes mellitus, end-stage renal disease (ESRD) on hemodialysis, peripheral vascular disease (PVD), prior transmetatarsal amputation (TMA), and chronic anemia, what is the optimal long-term oral anticoagulant to prevent complications?
What is the comprehensive management plan for an older adult with hypertension, type 2 diabetes, heart failure with reduced ejection fraction, and chronic pain, including medication selection, dose adjustments, and preventive measures?
In an 88‑year‑old woman with atrial fibrillation, coronary artery disease, hypertension, dyslipidemia, heart‑failure with preserved ejection fraction, chronic kidney disease stage III, gastro‑oesophageal reflux disease, and osteoporosis who was hospitalized for acute decompensated heart failure and rapid‑ventricular‑response atrial fibrillation but is now euvolemic and rate‑controlled, should she undergo catheter ablation or can amiodarone be discontinued while continuing metoprolol for rate control?
What treatment recommendations should be given for a nursing home resident with a chest X‑ray negative for pneumonia who has had desaturations requiring increased supplemental oxygen, cough, congestion, and episodes of apnea but no fever or chills?
What is the proper dosing and administration schedule for mirtazapine?
What is Paxil (paroxetine) and what are its indications, dosing, contraindications, and common side effects?
What is the recommended dosing of Augmentin (amoxicillin‑clavulanate) for an uncomplicated lower respiratory tract infection in an adult without beta‑lactam allergy?
What is the significance of a free testosterone of 0.4 ng/dL and a total serum testosterone of 7 ng/mL, and how should this be managed?
A patient with chronic auditory hallucinations who refuses clozapine (Clozaril) or haloperidol (Haldol), currently on olanzapine 30 mg at bedtime and risperidone (Risperdal) 2 mg twice daily for 4 days with persistent hallucinations, which first‑generation antipsychotic should be considered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.